论文部分内容阅读
新的抗早老性痴呆药申请上市ＦｏｒｅｓｔＬａｂｓ公司和拜耳公司已分别在美国提交了用于早老性痴呆的乙酰胆碱酯酶抑制剂的新药申请，即每天服用两次的Ｓｙｎａｐｔｏｎ（ｐｈｙｓｏｓｔｉｇｍｉｎｅ）和每天服用一次的ｍｅｔｒｉｆｏｎａｔｅ。在向美国提出申请之前，拜...
New Anti-Alzheimer’s Drugs Available ForestLabs and Bayer have submitted new drug applications for acetylcholinesterase inhibitors for Alzheimer’s disease in the United States, Synapton (physostigmine) taken twice daily and once daily metrifonate. Before applying to the United States, thanks ...